The ability of microbes to sense and respond to changes in environmental pH is critical for their survival. The Rim101/ PacC signal transduction pathway is required for adaptation to neutral-to-alkaline environments in fungi. This pathway is found throughout both yeast and molds of the ascomycota and has recently been identified in the basidiomycota (2, 6, 25) . The Rim101/PacC pathway is also important for pathogenesis in both animal and plant pathogens (5, 7) . Thus, the ability to respond to environmental pH is linked to the ability of fungi to cause disease.
The conserved Rim101/PacC pathway governs changes in gene expression through the zinc finger transcription factor Rim101/PacC, which is itself regulated by proteolytic processing. At an acidic pH, Rim101/PacC is found in either a fulllength (unprocessed) form or a processed form thought to be inactive; at alkaline pH, Rim101/PacC is found in a processed form that is capable of promoting changes in gene expression (6, 19, 25, 33) . Proteolytic processing is controlled by a number of upstream members of the pathway including Rim8/PalF, Rim13/PalB, Rim20/PalA, Rim21/PalH, and Snf7 (6, 8, 10, 15, 16, 19, 20, 26, 33, 34) . Furthermore, many members of the ESCRT (endosomal sorting complex required for transport) machinery, which includes Snf7, are required for Rim101 processing (34) . In total, these factors act to promote Rim101/ PacC processing and adaptation to neutral-to-alkaline environments.
In Saccharomyces cerevisiae, Rim101 appears to act primarily as a repressor of pH-dependent gene expression. In this system, Rim101-dependent induction of targets, such as ENA1, is indirect (17, 18) . Rim101 represses the expression of additional transcriptional repressors, such as Nrg1, which is a repressor of ENA1 expression. In fact, all of the Rim101 activity in S. cerevisiae can be attributed to its ability to repress transcription (17) . In Aspergillus nidulans, PacC appears to directly act as both a repressor and an inducer of pH-dependent gene expression (11, 25, 29) .
In Candida albicans, Rim101 acts as a repressor of genes expressed preferentially at acidic pH compared to alkaline pH and as an inducer of genes expressed preferentially at alkaline pH compared to acidic pH (4, 8, 26, 28) . However, its role as an inducer is more clearly defined. For example, Rim101 is required for the induction of PHR1 at a neutral-to-alkaline pH (8, 28) . Ramon and Fonzi previously demonstrated that a recombinant Rim101 DNA binding domain-glutathione S-transferase (GST) fusion binds directly to the PHR1 promoter. Furthermore, those authors showed that this binding is required for alkaline-pH-dependent induction of PHR1 (27) . In A. nidulans and S. cerevisiae, PacC/Rim101 binds with high affinity to the 5Ј-GCCAAG sequence (17, 27, 29) . However, the C. albicans PHR1 promoter does not contain a 5Ј-GC CAAG sequence. Interestingly, Ramon and Fonzi found that C. albicans Rim101 binds to the divergent 5Ј-CCAAGAA sequence. Thus, C. albicans Rim101 can act directly as an inducer of gene expression by binding to a divergent Rim101/ PacC binding site.
However, C. albicans Rim101 may not be specific for the divergent 5Ј-CCAAGAA sequence. We identified 186 alkaline-pH-induced and Rim101-dependent genes by transcriptional profiling (4) . Analysis of alkaline-pH-and Rim101-dependent promoters revealed the 5Ј-GCCAAGAA site as a conserved motif. This site contains both the classical 5Ј-GC CAAG and divergent 5Ј-CCAAGAA Rim101 binding sites. Thus, C. albicans Rim101 may in fact bind to a classical site motif.
While Rim101 clearly acts as an inducer in C. albicans, it is not known if it can directly act as a repressor. Rim101 binding sites can be found in the promoters of some genes repressed at alkaline pH in a Rim101-dependent manner, but analysis of the 20 most alkaline-pH-repressed Rim101-dependent promoters using the MEME algorithm did not identify a Rim101 binding site. Furthermore, in the absence of Rim101, all analyzed alkaline-pH-repressed Rim101-dependent genes became alkaline induced (4, 8) . This suggests that an additional factor(s) may regulate these genes. Thus, Rim101 may indirectly govern alkaline-pH-repressed gene expression through this other factor. This situation would mirror that in S. cerevisiae, where Rim101 indirectly acts as an inducer by repression of another transcriptional repressor (17) .
Here, we studied the role of C. albicans Rim101 in the repression of the PHR2 gene. PHR2 encodes a functional homolog of the Phr1 cell wall ␤-glycosidase and is expressed in a pH-and Rim101-dependent manner (14, 23) . However, unlike PHR1, PHR2 is expressed preferentially at acidic pH and is repressed at alkaline pH in a Rim101-dependent manner (8, 23) . Sequence analysis of a 1,000-bp region of the PHR2 promoter upstream of ATG identified three potential Rim101 binding sites at positions Ϫ575, Ϫ124, and Ϫ51, suggesting that PHR2 may be directly regulated by Rim101 (Fig. 1) . While all three sites are potential Rim101 binding sites, the Ϫ575 and Ϫ124 sites are in the opposite orientation. Furthermore, the Ϫ575 site specifies a classical consensus sequence, 5Ј-CTT GGC; the Ϫ124 site can specify both a classical and a divergent consensus sequence, 5Ј-TTCTTGGC; and the Ϫ51 site specifies only the divergent consensus sequence 5Ј-CCAAGAA. Through electrophoretic mobility shift assays (EMSAs) and LacZ reporter analyses, we found that specific Rim101 binding sites within the PHR2 promoter are important for Rim101-dependent repression at alkaline pH. Furthermore, we found that endogenous Rim101 binds to these sites in vitro and that binding does not require Rim101 processing. Thus, our studies demonstrate that Rim101 acts directly as a repressor of transcription in C. albicans. Finally, our results suggest that Rim101 binding activity is governed by an additional mechanism independent of proteolytic processing.
MATERIALS AND METHODS
Strains and plasmids. All strains used in these studies are listed in Table 1 and have been previously described.
The P PHR2 -driven lacZ construct pDDB225 was generated as follows. LacZ from Streptococcus thermophilus was amplified from pAU36 in a PCR (30) by using primers St. LacZ fus5Ј and Mlu-Not-ACT1 UTR ( Table 2 ). The resulting PCR product was ligated into pGEM-T Easy (Promega) to generate pDDB211. A total of 998 bp of the PHR2 promoter was amplified in a PCR using primers PHR2-1005 and PHR2-ATG, and the resulting PCR product was ligated into pGEM-T Easy to generate pDDB213. pDDB211 was digested with AseI/MluI and ligated into NdeI/MluI-digested pDDB213 to generate pDDB218. The P PHR2 -lacZ construct was removed from pDDB218 by SapI/NgoMIV digestion and transformed into a trp1 Ϫ S. cerevisiae strain with NotI/EcoRI-digested pDDB78 to generate pDDB225 by in vivo recombination (22) .
The Ϫ51 site-specific mutation within P PHR2 was derived from pDDB213 using primers PHR2-48mut 5aЈ and PHR2-48 mut 3aЈ using the GeneEditor system (Promega) to generate pDDB251. Next, pDDB211 was digested with AseI/MluI and ligated into NdeI/MluI-digested pDDB251 to generate pDDB252. The P PHR2-51 -lacZ construct was removed from pDDB252 by SapI/NgoMIV digestion and introduced into pDDB78 by in vivo recombination to yield pDDB254.
The Ϫ124 and Ϫ575 site-specific mutations were generated as follows. P PHR2 -lacZ was amplified in two fragments from pDDB225 using primers Pphr2-117m1b (or Pphr2-569m1) with 3Ј-detect and Pphr2-117m2b (or Pphr2-569m2) with 5ЈSnaBICaHis1. These two fragments were introduced into NheI/ClaIdigested pDDB225 by in vivo recombination, resulting in pDDB255 for Ϫ124 site-specific mutation and pDDB256 for Ϫ575 site-specific mutation.
The double mutations at positions Ϫ51 and Ϫ124, Ϫ51 and Ϫ575, and Ϫ124 and Ϫ575 were generated by the same strategy used for the Ϫ124 and Ϫ575 site-specific mutations with the same primers using NheI/ClaI-digested pDDB254 for the double mutations at positions Ϫ51 and Ϫ124 and Ϫ51 and Ϫ575 and pDDB333 for the double mutations at positions Ϫ124 and Ϫ575 to yield pDDB334, pDDB335, and pDDB336, respectively, after in vivo recombination. The triple mutation at positions Ϫ51, Ϫ124, and Ϫ575 was generated using NheI/ClaI-digested pDDB335 to yield pDDB337. The Ϫ124 point mutations for the classical and divergent Rim101 binding consensus sequences (GCCAAGAA) were generated by in vivo recombination between two amplified P PHR2 -lacZ fragments using primers Pphr2-117 aCCAAGA 5Ј (or Pphr2-117 GCCAAGg-5Ј) with 3Ј-detect and Pphr2-117 aCCAAGA 3Ј (or Pphr2-117 GCCAAGg-3Ј) with 5ЈSnaBICaHis1 and NheI/ClaI-digested pDDB225 to yield pDDB338 and pDDB339, respectively. Plasmids pDDB225, pDDB254, and pDDB332 through pDDB339 were digested with NruI and transformed into DAY1 and DAY432 to generate strains for ␤-galactosidase assays. Correct integration was verified by PCR with the primers PHR2-1005 and LacZ ϩ 354c. The PHR2 promoter region of all plasmid constructs was confirmed by sequencing.
Media and growth conditions. C. albicans was routinely grown in yeast extractpeptone-dextrose plus uridine (2% Bacto peptone, 1% yeast extract, 2% dextrose, and 80 g of uridine per ml). Selection for the His ϩ transformants was done on synthetic medium (0.67% yeast nitrogen base plus ammonium sulfate and without amino acids, 2% dextrose, and 80 g of uridine per ml supplemented with the required auxotrophic needs of the cells).
␤-Galactosidase assays. For liquid ␤-galactosidase assays, cell pellets grown to mid-log phase in 35 ml of pH 4 or pH 8 M199 medium with 150 mM HEPES were resuspended in 1 ml Z buffer (1) . Each cell suspension was diluted 20-fold to determine the optical density at 600 nm. One hundred fifty microliters of cell suspension was then added to a mixture of 0.1% sodium dodecyl sulfate (SDS) and chloroform for permeabilization. After a 10-min incubation at 37°C, 0.7 ml ONPG (o-nitrophenyl-␤-D-galactopyranoside) (1 mg/ml) was added for the ␤-galactosidase reaction. Reactions were terminated by adding 0.5 ml 1 M Na 2 CO 3 when the solution turned yellow, and the A 420 was determined. Miller units were calculated as follows: A 420 /(optical density at 600 nm ϫ volume assayed ϫ time) (1) . Data were analyzed by analysis of variance to determine statistical relationships.
Protein preparation. Cultures were grown to saturation overnight in yeast extract-peptone-dextrose plus uridine. Cells were diluted 40-fold into M199 medium buffered with 150 mM HEPES to pH 4 or pH 8 and grown for 4 h at 30°C. Cells were pelleted and stored at Ϫ80°C prior to protein extraction. Cell pellets were resuspended in ice-cold radioimmunoprecipitation assay buffer containing 1 g/ml leupeptin, 2 g/ml aprotinin, 1 g/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride, and 10 mM dithiothreitol and transferred into glass test tubes containing acid-washed glass beads. Cells were lysed by vortexing four times for 2 min, followed by 2 min on ice. Cell debris was removed by centrifugation, and supernatants were removed and stored at Ϫ80°C.
Western blot analyses. For Western blots, 20 l of 2ϫ SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer was added to 20 l supernatant, and samples were boiled for 5 min. Samples were loaded onto an 8% SDS-PAGE gel and run overnight at 35 V. Proteins were transferred onto nitrocellulose and blocked. Anti-V5-horseradish peroxidase (HRP) antibody (Invitrogen) in 30 ml 5% nonfat milk-Tris-buffered saline-Tween solution (1:7,500 dilution) was added to the blot for 4 h at 4°C. Blots were washed in Tris-buffered salineTween, incubated with ECL reagent (Amersham Biosciences), and exposed to film. Blots were analyzed using ImageJ software (NIH).
EMSA. EMSAs were performed as follows. Forty femtomoles of DNA probe was incubated with 20 g of cell extract in 20 l of binding buffer [10 mM Tris-HCl, pH 7.5, 4% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithio- threitol, 50 mM NaCl, 2 g of poly(dI-dC)] at room temperature for 30 min. DNA-protein complexes were resolved on 4% nondenaturing polyacrylamide gels in 0.5ϫ Tris-borate-EDTA buffer at room temperature overnight. After electrophoresis, the gels were dried and visualized with a phosphorimager. For supershift assays, 20 g of cell extract was incubated with 1 g of anti-V5-HRP antibody on ice for 30 min prior to the addition of the DNA probe, and the binding reaction was allowed to proceed for an additional 30 min at room temperature. All DNA probes were end labeled by T4 polynucleotide kinase with [␥-32 P]dATP. EMSAs were analyzed using ImageJ software (NIH).
RESULTS
Rim101 can bind to all three Rim101 binding sites within the PHR2 promoter. Previous studies demonstrated that PHR2 expression is pH and Rim101 dependent (8) . We predicted that this regulation was due to Rim101 binding sites within the PHR2 promoter. To biochemically test this possibility, we conducted ESMAs using C. albicans whole-cell protein extracts. Previous studies demonstrated that a recombinant Rim101 DNA binding domain-GST fusion bound to the PHR1 promoter by EMSA (27) . Thus, we first assessed the binding of endogenous Rim101 to the PHR1 promoter. Radiolabeled DNA probes were generated by annealing the PHR1 oligomers BS-825sh and BS-825shc (27) and end labeling. The resulting probes were incubated with protein extracts from wild-type cells, separated by nondenaturing PAGE, and analyzed on a phosphorimager. EMSA of these probes incubated with protein extracts from wild-type cells revealed two distinct gel shift bands compared to free probe (noted as A and B in Fig. 2 , lanes 1 and 2). Radiolabeled DNA probes were next generated using oligomers BS-825Xsh and BS-825Xshc (27) , which contain a mutated Rim101 binding site, and incubated with protein extracts from wild-type cells. EMSA of these mutated probes revealed a gel shift to band A but not to band B (Fig.   2 , lane 3). Similar results were obtained using radiolabeled DNA probes from oligomers BS-825sh and BS-825shc and protein extracts from rim101 Ϫ/Ϫ cells (Fig. 2, lane 4) . These results extend the results described previously by Ramon and Fonzi (27) and suggest that endogenous Rim101 binds to the divergent sequence 5Ј-CCAAGAA of the PHR1 promoter.
We next determined whether each of the putative Rim101 binding sites within the PHR2 promoter can interact with Rim101. Radiolabeled 35-bp DNA probes that span the Ϫ575, Ϫ124, or Ϫ51 putative Rim101 binding site were generated by annealing probes PHR2-569 5Ј and PHR2-569 3Ј, PHR2-117 5Ј and PHR2-117 3Ј, or PHR2-48 5Ј and PHR2-48 5Ј, respectively, and end labeling. Like the results observed for the PHR1 probe, EMSA of these probes incubated with protein extracts from wild-type cells revealed two distinct gel shift bands (A and B) (Fig. 2, lanes 2, 6, 10, and 14) . However, there was less gel shift to band B observed for the PHR2 probes than for the PHR1 probes. These results demonstrate that a protein(s) is able to bind to the PHR2 promoter fragments.
We next asked whether the gel shifts observed with the PHR2 promoter fragments were dependent on the predicted Rim101 binding sites. Oligomers in which the core sequence found in both the classical and divergent Rim101 binding sites was changed from 5Ј-CCAAG to 5Ј-CCGGC (change is underlined) were designed. Radiolabeled probes that span the Ϫ575, Ϫ124, or Ϫ51 site and that contain these mutations were generated using oligomers PHR2-569mut 5Ј and PHR2-569mut 3Ј, PHR2-117mut 5Ј and PHR2-117mut 3Ј, and PHR2-48mut 5Ј and PHR2-48mut 5Ј, respectively. EMSA of these mutated probes incubated with protein extracts from wild-type cells revealed a dramatic decrease in the amount of probe shifted to band B but not band A, similar to results seen for the PHR1 binding site (Fig. 2, lanes 3, 7, 11 , and 15). Finally, probes derived from oligomer probes PHR2-569 5Ј and PHR2-569 3Ј, PHR2-117 5Ј and PHR2-117 3Ј, and PHR2-48 5Ј and PHR2-48 5Ј were incubated with protein extracts from rim101 Ϫ/Ϫ cells and analyzed by EMSA (Fig. 2, lanes 4, 8, 12 , and 16). Again, a drastic reduction in probe shifted to band B but not band A was observed, supporting the idea that these PHR2 site promoter fragments interact with Rim101 through the Rim101 binding site.
The fact that the mutated PHR1 and PHR2 DNA probes failed to interact with Rim101 strongly suggests that this interaction is specific. To further address this possibility, we conducted competition EMSAs. We first analyzed the ability of cold wild-type PHR1 or mutated PHR1 DNA fragments, generated by annealing the primer pairs described above, to compete for Rim101 binding to a radiolabeled wild-type PHR1 probe (Fig. 3) . The addition of 30-fold excess cold wild-type PHR1 DNA fragment effectively abolished most of the Rim101-dependent gel shift (Fig. 3A, lane 2) . However, the addition of 1,000-fold excess cold mutated PHR1 DNA fragment was required to reduce the Rim101-dependent gel shift to band B (Fig. 3A, lane 9 ). We noted that band A was effectively competed with either cold competitor, suggesting that this band is a nonspecific artifact. We next analyzed the ability of cold wild-type Ϫ124 and mutated Ϫ124 PHR2 DNA fragments, generated as described above, to compete for Rim101 binding to the radiolabeled wild-type Ϫ124 probe. The addition of 30-fold excess cold wild-type Ϫ124 PHR2 DNA frag- (Fig. 3B, lane 2) . However, the addition of 300-fold excess cold mutated Ϫ124 PHR2 DNA fragment was required to similarly reduce the Rim101-dependent gel shift (Fig. 3B, lane 8) . These results support the idea that the band B gel shift is due to a specific Rim101-dependent interaction.
Although these results implicate Rim101 as the factor responsible for the gel shift, it is possible that another factor, which is itself Rim101 dependent, binds to the putative Rim101 binding sites in the PHR2 promoter. To establish whether the gel shifts observed are directly due to Rim101, we conducted EMSAs using extracts from rim101 Ϫ/Ϫ ϩ RIM101-V5 cells, which express only epitope-tagged Rim101-V5 (19) . Protein extracts from rim101 Ϫ/Ϫ ϩ RIM101-V5 cells showed gel shift patterns with the PHR1 and PHR2 probes and the mutated PHR2 probes similar to wild-type protein extracts (Fig. 4, lanes 2, 5, 8 , and 11 and data not shown). However, protein extracts from rim101 Ϫ/Ϫ ϩ RIM101-V5 cells incubated with an anti-V5-HRP antibody and the PHR1 and PHR2 probes resulted in a supershift C band (Fig. 4, lanes 3, 6, 9, and 12) . Concomitant with the presence of the C band, there was a loss of the B band but not the A band. No band C gel shift was observed using protein extracts from a strain carrying the V5 epitope tag within the Snf7 protein, demonstrating that the V5 epitope tag was not conferring DNA binding ability (data not shown). Thus, in total, these results suggest that endogenous Rim101 can interact with all three Rim101 binding sites within the PHR2 promoter.
The ؊124 binding site is the most important site in vivo. Rim101 appears to bind to all three putative binding sites within the PHR2 promoter in vitro. However, these assays contain a vast excess of probe as demonstrated by the amount of unbound probe shown in Fig. 2 , so it is possible that these interactions are artifacts of the in vitro assay. Thus, we asked whether these sites were important in vivo. In order to address this issue, we constructed a LacZ reporter driven from the PHR2 promoter. The PHR2 promoter region, containing all three putative Rim101 binding sites, was amplified by PCR and cloned next to lacZ from S. thermophilus (30) . The resulting P PHR2 -lacZ reporter was introduced into plasmid pDDB78 and transformed into wild-type and rim101 Ϫ/Ϫ C. albicans strains (Table 3 ). In wild-type cells, P PHR2 -lacZ was repressed ϳ30-fold when cells were grown at pH 8 compared to pH 4. In rim101 Ϫ/Ϫ cells, P PHR2 -lacZ expression was similar to that of wild-type cells at pH 4 but was now overexpressed about twoto threefold at pH 8. These results are consistent with Northern blot data, which demonstrated that PHR2 is expressed preferentially at pH 4 compared to pH 8 in wild-type cells and was expressed about threefold more at pH 8 than at pH 4 in rim101 Ϫ/Ϫ cells (8) . Thus, the P PHR2 -lacZ construct is expressed in a pH-and Rim101-dependent manner.
To determine if the putative Rim101 binding sites confer pHand/or Rim101-dependent expression, we generated site-specific mutations in each of the three sites and assayed the effect of these mutations on LacZ expression. We first mutated the Ϫ51 and the Ϫ575 sites, which were changed from 5Ј-aCCAAGAA to 5Ј-gC CggcAA and from 5Ј-CTTGGC to 5Ј-gccGGC, respectively, and then analyzed LacZ expression at pH 4 and pH 8 (Table 3) (underlining represents mutations compared to the wild-type sequence, capital letters are the Rim101 binding site, and lowercase indicates a mutation or non-Rim101 binding site nucleotide). In wild-type cells at pH 4, P PHR2-575 -lacZ was expressed at slightly reduced levels compared to P PHR2 -lacZ (P Ͻ 0.0015), although no effect was observed for P PHR2-51 -lacZ. At pH 8, both P PHR2-51 -lacZ and P PHR2-575 -lacZ were repressed ϳ20-fold, which was not significantly different than that of the wild-type P PHR2 -lacZ fusion (P ϭ 0.071 and 0.48, respectively). Thus, the Ϫ51 and Ϫ575 sites do not have a dramatic effect on PHR2 pH-dependent expression. 5) cold competitor, or in the presence of 30-to 1,000-fold excess mutant (mut) (lanes 6 to 9) cold competitor.
FIG. 4. Supershift assays demonstrate that Rim101 binds to promoter regions containing the Rim101 binding site. Protein extracts from rim101
Ϫ/Ϫ ϩ RIM101-V5 (DAY492) cells grown at pH 8 incubated with anti-V5-HRP antibody (V5) (lanes 3, 6, 9, and 12) or without anti-V5-HRP antibody (ϩ) (lanes 2, 5, 8, and 11) were allowed to bind to DNA probes for wild-type PHR1 or PHR2 (Ϫ575, Ϫ124, and Ϫ51) promoters. Lanes 1, 4, 7, and 10 contain free probe (fp) without protein extract.
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We next mutated the Ϫ124 site from 5Ј-TTCTTGGC to 5Ј-TTgccGGC and analyzed expression. In wild-type cells at pH 4, P PHR2-124 -lacZ was expressed at reduced levels compa red to P PHR2 -lacZ (P Ͻ 5 ϫ 10 Ϫ5 ), suggesting that bases at the Ϫ124 site may play a role in basal transcription. In wild-type cells at pH 8, P PHR2-124 -lacZ showed only twofold repression, which is ϳ15-fold less repression than that observed for P PHR2 -lacZ. This suggests that the Ϫ124 site plays a dramatic role in PHR2 pH-dependent expression.
In rim101 Ϫ/Ϫ cells at pH 4, P PHR2-51 -lacZ, P PHR2-124 -lacZ, and P PHR2-575 -lacZ were expressed at levels similar to those observed in wild-type cells. P PHR2-124 -lacZ and P PHR2-575 -lacZ were overexpressed like P PHR2 -lacZ in the rim101 Ϫ/Ϫ background. However, at pH 8, P PHR2-51 -lacZ was overexpressed significantly less than P PHR2 -lacZ in the rim101 Ϫ/Ϫ background (P Ͻ 0.0093). These results suggest that the Ϫ51 site, but not the Ϫ124 and the Ϫ575 sites, may play a role in PHR2 Rim101-independent transcriptional regulation.
The Ϫ124 site appears to be the most important site for the pH-dependent repression of PHR2. However, alkaline-pH-dependent repression was still present in the P PHR2-124 -lacZ construct. To determine if this residual repression was conferred by the Ϫ51 and/or Ϫ575 site, we constructed P PHR2 -lacZ fusions that contained mutations in two or three of the putative Rim101 binding sites and analyzed expression in wild-type and rim101 Ϫ/Ϫ cells ( Table 3 ). The P PHR2-124,-575 -lacZ construct had no differences in lacZ expression compared to the P PHR2-124 -lacZ construct at either pH 4 or pH 8. Furthermore, in the wild-type background, the P PHR2-51,-575 -lacZ double-mutant construct was not statistically different from the P PHR2-51 -lacZ construct. These results support the idea that the Ϫ575 site is not critical for PHR2 pHdependent regulation. However, the P PHR2-51,-124 -lacZ construct showed a significant difference in lacZ expression compared to the P PHR2-124 -lacZ construct at pH 4 (P Ͻ 0.0015), suggesting that the Ϫ51 site in conjunction with the Ϫ124 site plays a role in basal transcription. At pH 8, the P PHR2-51,-124 -lacZ construct did not have any significant repression compared to pH 4 levels. This was distinct from the Ϫ124 mutation alone, which retained twofold repression. These results suggest that the Ϫ51 site contributes to the pH-dependent regulation of PHR2. Finally, we found that the P PHR2-51,-124,-575 -lacZ construct showed no significant differences compared to the P PHR2-51,-124 -lacZ construct in either the wild-type or rim101 Ϫ/Ϫ background regardless of pH. These results demonstrate that Rim101-dependent repression is conferred by the Ϫ51 and Ϫ124 sites alone and that the Ϫ575 site does not play a role in the Rim101-or pH-dependent regulation of PHR2.
The ؊124 site acts as a classical Rim101 binding site. Based on the LacZ assays, the Ϫ124 Rim101 binding site is the primary site for pH-and Rim101-dependent expression. Interestingly, this site is both a classical and a divergent site (5Ј-TTC TTGGC). To determine if this site is acting as either a classical or a divergent site, we conducted EMSAs using mutations in nucleotides specific for either the classical (the C in position 8) a ␤-Galactosidase assays were performed on P PHR2 -lacZ reporter strains grown at pH 4 and pH 8. At least three independent transformants were used to determine average Miller units and standard deviations.
or the divergent (the T in position 2) sites. Protein extracts from wild-type cells shifted the radiolabeled DNA fragment spanning the wild-type Ϫ124 site but not a mutated Ϫ124 site ( Fig. 2 and 5, lanes 1 and 2) . Importantly, protein extracts from wild-type cells were also unable to shift the DNA fragments containing a mutation in either the classical site (⌬C) or the divergent site (⌬D) (Fig. 5, lanes 3 and 4) . Based on these results, nucleotides specific to both the classical and divergent sites of the Ϫ124 site are critical for Rim101 binding in vitro.
To further address this issue, we constructed the same sitespecific mutations to disrupt either the classical or divergent binding sites in the P PHR2 -lacZ construct to generate P PHR2-124⌬C -lacZ and P PHR2-124⌬D -lacZ, respectively. These constructs were introduced into the wild-type and rim101 Ϫ/Ϫ backgrounds, and ␤-galactosidase activity was determined (Table 3 ). In wild-type cells at pH 4, mutation of either the classical or the divergent site reduced expression compared to the P PHR2 -lacZ construct (P Ͻ 0.004 and P Ͻ 3 ϫ 10 Ϫ5 , respectively), although the divergent site mutation had a greater reduction in expression, similar to that observed for the P PHR2-124 -lacZ construct at pH 4. At pH 8, the classical-site mutation resulted in about fourfold repression compared to that at pH 4; the divergent-site mutation resulted in about eightfold repression. While mutation of the classical and divergent sites reduced pH-dependent repression compared to the P PHR2 -lacZ construct, the classical site mutation had the greatest effect on pH-dependent repression. These results demonstrate that the C in position 8 of the Ϫ124 site, which specifies a classical Rim101 binding site, is important for pH-dependent expression.
Rim101 processing is not required for DNA binding. Previous studies, as well as those described above, demonstrated that Rim101 can bind to Rim101-dependent promoters (27) . However, these analyses did not address whether Rim101 processing affects DNA binding. To address this question, EMSAs were conducted using protein extracts from a rim13 Ϫ/Ϫ strain, which does not process Rim101 (19) . Using whole-cell extracts from rim13 Ϫ/Ϫ cells grown at pH 8, in the presence of the PHR1, PHR2 Ϫ575, PHR2 Ϫ124, or PHR2 Ϫ51 radiolabeled probes, a gel shift was observed (Fig. 6, lanes 1, 3, 5, and 7) . However, in the presence of the PHR1, PHR2 Ϫ575, PHR2 Ϫ124, or PHR2 Ϫ51 radiolabeled probes containing a mutated Rim101 binding site, a dramatic reduction in gel shift was observed (Fig. 6, lanes 2, 4, 6, and 8) . These results are similar to those observed for protein extracts from wild-type cells and demonstrate that full-length Rim101 can bind to the Rim101 binding site.
Environmental pH affects Rim101 binding activity. Like other fungi, C. albicans Rim101 is processed to an active form at alkaline pH. However, unlike other fungi, it is also processed to a novel 65-kDa form at acidic pH (19) . To determine if the 65-kDa processed form can bind promoters, we conducted EMSAs on wild-type cells grown at either alkaline or acidic pH. As observed previously, protein extracts from wild-type cells grown at pH 8 shifted the PHR1, PHR2 Ϫ575, PHR2 Ϫ124, and PHR2 Ϫ51 radiolabeled probes but not the mutated radiolabeled probes (Fig. 7A, lanes 9 to 16) . Protein extracts from wild-type cells grown at pH 4 also shifted the PHR1, PHR2 Ϫ575, PHR2 Ϫ124, and PHR2 Ϫ51 radiolabeled probes (Fig. 7A, lanes 1 to 8) , but surprisingly, there was a dramatic reduction in gel shift from cells grown at pH 4 compared to cells grown at pH 8 (for example, compare lanes 1 and 9 in Fig.  7A ). The pH of the protein extracts following purification was not affected by the pH of the growth medium, demonstrating that these results are not due to a pH-dependent effect on protein-DNA complex formation for the EMSA. We also considered the possibility that there was less Rim101 protein from the cells grown at pH 4, compared to the cells grown at pH 8, that would account for this reduction in DNA binding activity. Thus, 250 g of the protein extracts used for the EMSA was run on Western blots and probed using the anti-V5 antibody (Fig. 7A, lanes 17 and 18) . While we observed slightly more Rim101 protein at pH 8 than at pH 4 (1.2-fold), this difference does not account for the fivefold decrease in DNA binding activity observed in cultures grown at pH 4 compared to cultures grown at pH 8. These results suggest the possibility that Rim101 may not be as competent to bind to the Rim101 binding site in promoters from cells grown at pH 4 compared to pH 8.
Since there are distinct processed forms of Rim101 at pH 4 and pH 8 (19), we considered the possibility that one or more of these forms may promote or inhibit the DNA binding activity. Since processing is not required for DNA binding activity in vitro (Fig. 6) , we conducted EMSAs using protein extracts from rim13 Ϫ/Ϫ cells, which express only the full-length form of Rim101 (19) . Similar to the results described above, protein extracts from rim13 Ϫ/Ϫ cells grown at pH 4 did shift the PHR1, PHR2 Ϫ575, PHR2 Ϫ124, and PHR2 Ϫ51 radiolabeled probes (Fig. 7B, lanes 1 to 8) . However, the amount of probe shifted from cells grown at pH 4 was dramatically reduced compared to the amount shifted from cells grown at pH 8 ( Fig.   FIG. 5 . The Ϫ124 site acts as a classical and divergent Rim101 binding site by EMSA. Protein extracts from wild-type (DAY286) cells grown at pH 8 were incubated with DNA probes for the endogenous (ϩ), the mutated (Ϫ), the classical-site mutated (⌬C), and the divergent-site mutated (⌬D) sequences of the Ϫ124 PHR2 site. 7B, lanes 9 to 16). Furthermore, Western blot analyses of the rim13 Ϫ/Ϫ protein extracts used for the EMSAs showed that comparable amounts of Rim101 protein were purified from the cultures grown at pH 4 and those grown at pH 8 (Fig. 7B, lanes  17 and 18) . These results indicate that the difference between the Rim101 DNA binding activity observed at pH 4 compared to that observed at pH 8 is clearly not due to differences in Rim101 protein concentration. Furthermore, these results demonstrate that this pH-dependent DNA binding activity is not mediated by the different processed forms of Rim101. Thus, we infer that another factor, which is pH dependent, affects the ability of the Rim101 protein to interact with DNA.
DISCUSSION
The mechanism of Rim101/PacC transcriptional regulation has been the focus of studies of numerous fungi, including S. cerevisiae, A. nidulans, and C. albicans (6, 25) . In A. nidulans, PacC acts directly as an activator of genes such as ipnA and as a repressor of genes such as gabA (11, 13) . In S. cerevisiae, Rim101 has been shown only to act directly as a repressor of genes such as NRG1 and SMP1 (17) . In C. albicans, Ramon and Fonzi previously demonstrated that Rim101 is a direct activator of PHR1 transcription (27) . Based on the studies presented here, we demonstrate that C. albicans Rim101 can interact with PHR2 promoter elements, that this interaction requires the Rim101 binding site, and that these interactions are important in vivo. While we cannot rule out the possibility that Rim101 associates with these sites indirectly through an additional factor, the simplest model suggests that Rim101 is a direct repressor of PHR2 transcription. Thus, C. albicans Rim101 appears to act like A. nidulans PacC in that it clearly has both positive and negative transcriptional regulatory functions. Furthermore, we were able to demonstrate that endogenous Rim101 is capable of binding to promoters of alkaline-pHinduced genes, PHR1, and promoters of alkaline-pH-repressed genes, PHR2. We were also able to establish that Rim101 processing is not required for DNA binding, similar to results obtained for S. cerevisiae and A. nidulans (17, 24) . However, in vivo, processing promotes PacC nuclear localization (21), and we expect this to also be the case for C. albicans.
The PHR2 promoter contains three sequences that are predicted classical or divergent Rim101 binding sites (13, 27) . The most distal site, at position Ϫ575, is strictly a classical Rim101 binding site (5Ј-CTTGGC). We found that Rim101 could bind to this site in vitro; however, the Ϫ575 site is not required for pH-dependent regulation in vivo. Thus, Rim101 binding to the Ϫ575 site in vivo is neither necessary nor sufficient to repress PHR2 expression. The most proximal site, at position Ϫ51, is strictly a divergent Rim101 binding site (5Ј-CCAAGAA). We found that Rim101 could also bind to this site in vitro. However, in vivo studies demonstrated that while the Ϫ51 site is not required for pH-dependent regulation, it can play a role when the Ϫ124 site is mutated (see below).
The Ϫ124 site can specify both a classical and a divergent site (5Ј-TTCTTGGC), and this site binds Rim101 in vitro. However, unlike the Ϫ51 and Ϫ575 sites, the Ϫ124 site confers most of the pH-dependent regulation observed for PHR2. While the Ϫ124 site is required for PHR2 repression, there is still residual repression when the Ϫ124 site is mutated. This residual repression is now dependent on the Ϫ51 site, suggesting that this site may indeed be involved in PHR2 regulation in vivo.
In the absence of Rim101, the normally alkaline-pH-repressed PHR2 becomes an alkaline-pH-induced gene. Interestingly, we found that mutation of the Ϫ51 site, but not the Ϫ124 or the Ϫ575 site, impaired alkaline induction in the rim101
background. In all cases where the Ϫ51 site is intact, lacZ is induced more than twofold at alkaline pH in the rim101 Ϫ/Ϫ background. However, in all cases where the Ϫ51 site is mutated, lacZ is induced less than twofold at alkaline pH in the rim101 Ϫ/Ϫ background. One possibility is that this region of the PHR2 promoter is important for RNA polymerase binding or stability. However, lacZ expression at acidic pH is similar when driven from the PHR2 promoter containing an intact Ϫ51 site, a mutated Ϫ51 site, and the mutated Ϫ51 and Ϫ575 sites, suggesting that the Ϫ51 site is not required for general transcription. Thus, the Ϫ51 site may recruit a factor that promotes gene expression at alkaline pH in the absence of Rim101.
What is the Rim101 binding site? Previous work of Ramon and Fonzi, and work also described here, clearly demonstrates that C. albicans Rim101 does not require the first G of the classical site for binding (see Fig. 2 , specifically, the PHR1 and the PHR2 Ϫ51 lanes). This is contrary to findings for A. nidulans, which demonstrated that any other nucleotide in the first (13) . However, in C. albicans, the requirement for a G in this position is binding site dependent. For the PHR1 Rim101 binding site and the PHR2 Ϫ51 site, there is no G in the first position, yet Rim101 binds to these sites in vitro, and these sites are relevant in vivo. However, for the PHR2 Ϫ124 site, there is a G in the first position that is essential for Rim101 binding in vitro and important for repression in vivo.
Computer analysis of promoters from Rim101-dependent alkaline-pH-induced genes identified the consensus sequence GCCAAGAA, supporting the idea that the first G is often important for Rim101-dependent regulation (4). Thus, we propose that, in general, the Rim101 binding site can be considered GCCAAGAA, although divergence from this site can be tolerated. Support for this idea comes from A. nidulans. For example, the A in position 5 of the PacC site is frequently a G (5Ј-GCCAGG), although this results in lower-affinity binding (12) . Furthermore, in the gabA promoter, the A in position 4 can be changed with no apparent effect on PacC binding (11); however, in the ipnA promoter, the A in position 4 is essential for PacC binding (29) . Finally, our EMSAs revealed that Rim101 binds more efficiently to the Rim101 binding site of the PHR1 promoter than to any of the PHR2 binding sites, including the Ϫ51 and Ϫ124 sites, which share the CCAAGAA sequence. This result is supported by competition studies (unpublished data). Thus, we suggest that the ability of Rim101 to bind to the consensus sequence GCCAAGAA is context dependent. Why is the Ϫ575 site dispensable for Rim101-mediated PHR2 regulation? One possibility is that the orientation of the binding site is important for Rim101-dependent regulation. This does not seem likely, since the Ϫ124 site, which plays the major role in PHR2 repression, is in the same orientation as the Ϫ575 site. Another possibility is that this site is too far away from the transcriptional start site. In the case of the PHR1 promoter, the Rim101 binding sites are located at positions Ϫ516 and Ϫ825. Thus, the distance from the transcriptional start site does not appear to be a sufficient explanation. However, if Rim101 repression is mediated by inhibiting the binding of an activator, then binding site location is critical. In A. nidulans, expression of gabA is governed by the transcriptional activator IntA (3). However, gabA is repressed at alkaline pH in a PacC-dependent manner. Repression occurs because the PacC binding sites overlap with the IntA binding site (11) . At alkaline pH, PacC is active and binds to the gabA promoter, which excludes IntA from binding to its site. Thus, we propose that a similar mechanism may occur in C. albicans PHR2 Rim101-dependent repression. Support for this model comes from the fact that in the absence of Rim101, PHR2 becomes an alkaline-pH-induced gene, suggesting that additional factors are at play.
Our results strongly suggest the existence of additional regulatory factors that govern PHR2 expression. First, as stated above, PHR2 becomes an alkaline-pH-induced gene in the absence of Rim101. If Rim101 were the only factor involved in expression, then PHR2 should be expressed similarly at acidic and alkaline pHs. This additional regulatory control does not appear to be PHR2 specific, as several genes repressed at alkaline pH in a Rim101-dependent manner become alkaline induced in the absence of Rim101 (4). Second, from our EMSAs, we have found at least one additional DNA-protein complex that results in a band that we refer to as band A (see Fig. 2, for example) . While this band may be a nonspecific artifact, it appears that the Ϫ51 site was not as efficiently shifted to band A compared to the PHR1 binding site or the PHR2 Ϫ124 and Ϫ575 sites, suggesting some specificity in binding (Fig. 4) . For example, all of the sequences that are shifted to band A also contain an uninterrupted stretch of eight to nine A residues, whereas the longest run of As in the Ϫ51 site is three residues.
Finally, we found that Rim101 binding to DNA is dependent on the pH in which the cells were grown. This pH-dependent binding was not an attribute of processing, as Rim101 isolated from rim13 Ϫ/Ϫ cells was able to efficiently bind to the Rim101 binding site when isolated from cells grown at alkaline pH but not when isolated from cells grown at acidic pH. Thus, we propose that at acidic pH, Rim101 binding activity is inhibited by an as-yet-unidentified factor or that at alkaline pH, Rim101 binding activity is promoted by an unidentified factor. Regardless, we are unaware of any previous descriptions of Rim101 regulation except for the well-described proteolytic processing. Thus, in addition to proteolytic activation, C. albicans appears to have at least one additional mechanism to regulate Rim101 activity.
